Fortress Biotech, Inc. — Director's Dealing 2012

Apr 25, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CORONADO BIOSCIENCES INC (CNDO)
CIK: 0001429260
Period of Report: 2012-04-19

Reporting Person: Hehenberger Karin M. (See Remarks)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	925	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to purchase Common Stock	$6.00	2021-12-18	Common Stock (100000)		Direct
Options to purchase Common Stock	$7.84	2022-04-18	Common Stock (125000)		Direct

Footnotes

F1: One-third of the shares will vest on each of December 19, 2012, 2013 and 2014.

F2: One-third of the shares will vest on each of April 19, 2013, 2014 and 2015.